mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-05 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |